There could be a further window of opportunity: FY22 numbers.
Currently the market is expecting EPS of around 30c for FY21, but the market is expecting that number to increase to 38c by FY22.
I think with the delays in vaccinations, that FY22 actuals could disappoint.
Updated outlooks could occur in October in preparation for the Nov AGM.
I think first half FY22 could disappoint.
If updated outlooks really disappoint consensus expectations (remembering that by Oct/Nov, consensus is for earnings growth of more than 20% in FY 22, so stable numbers will not meet consensus), then despair will really settle in, and this will present an incredible opportunity for long term entry.
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-18789
-
- There are more pages in this discussion • 6,442 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.85 |
Change
0.000(0.00%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1322 | $7.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.55 | 46 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 715 | 7.190 |
1 | 1381 | 7.180 |
1 | 66 | 7.060 |
1 | 108 | 7.050 |
2 | 3499 | 6.990 |
Price($) | Vol. | No. |
---|---|---|
6.550 | 46 | 3 |
6.610 | 5064 | 1 |
6.730 | 843 | 1 |
6.750 | 1300 | 2 |
6.810 | 500 | 1 |
Last trade - 09.58am 16/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online